Jupiter Asset Management’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Jupiter Asset Management’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-82,508	Closed	-$2.91M	–	678
2020 Q3	$2.91M	Hold	82,508	–	–	0.03%	378
2020 Q2	$3.49M	Hold	82,508	–	–	0.12%	165
2020 Q1	$6.63M	Hold	82,508	–	–	0.29%	99
2019 Q4	$7.6M	Hold	82,508	–	–	0.23%	114
2019 Q3	$6.24M	Buy	+82,508	New	+$6.34M	0.2%	123

Other funds holding EVFM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

TWMP

Taylor Wealth Management Partners Boston, Massachusetts $176M AUM 14.65% 1-Year Est. Return

Jupiter Asset Management's EVFM Position: Q4 2020 in Review

Jupiter Asset Management sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q4 2020, closing a stake of 82,508 shares — an estimated $2.91M sold.

Jupiter Asset Management first reported a position in EVFM in Q3 2019 and held it in 5 quarters. The position peaked at $7.6M in Q4 2019. 93 funds tracked by Wall St. Rank hold EVFM as of Q4 2020.

Jupiter Asset Management reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Jupiter Asset Management sold 82,508 Evofem Biosciences, Inc. Common Stock shares in Q4 2020, an estimated $2.91M.
Jupiter Asset Management first reported a position in Evofem Biosciences, Inc. Common Stock in Q3 2019 and held it in 5 quarters.
Jupiter Asset Management's Evofem Biosciences, Inc. Common Stock position peaked at $7.6M in Q4 2019.
93 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q4 2020.

Based on Jupiter Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.